Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
12.12
+11.60 (2,221.84%)
At close: Mar 28, 2025, 4:00 PM
11.45
-0.67 (-5.53%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Aclarion Employees
As of December 31, 2023, Aclarion had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$8,215
Profits / Employee
-$1,046,807
Market Cap
456.02K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACON News
- 17 days ago - Aclarion Provides Shareholder Update - GlobeNewsWire
- 24 days ago - Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey - GlobeNewsWire
- 27 days ago - Aclarion Announces First Commercial Agreement with Scripps Health - GlobeNewsWire
- 5 weeks ago - Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit - GlobeNewsWire
- 6 weeks ago - Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body - GlobeNewsWire
- 7 weeks ago - Aclarion Announces Northwestern Medicine as First CLARITY Trial Site - GlobeNewsWire
- 7 weeks ago - Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded - GlobeNewsWire
- 4 months ago - Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash - GlobeNewsWire